March 9, 2010: Medical Device Breakfast Series | Strategies to Expedite Revenues
With the average cost to develop a new medical device in excess of $100 million, companies have little choice but to improve the efficiency of their research, development, and commercialization processes. Not all commercialization strategies are equally effective for all products, companies or business objectives, and some are simply the wrong choice for a given set of circumstances. There is a range of well proven product commercialization strategies for medical devices intended to expedite revenues: technology transfers, strategic partnering with the established market players, use of independent specialty distributors. Increasingly, with a more adversarial domestic regulatory environment, many companies pursue commercialization in Europe first to develop an income stream. Some are even entering Europe with no intention of seeking US approval. Join a group of medical device veterans discussing commercialization strategies, both domestically and abroad, opportunities and pitfalls to avoid. In Palo Alto.
Detailed Information
March 11, 2010: BayBio NEST | Heart Matters: Investments in Heart Disease
Heart disease is the leading cause of death worldwide, killing one person every 34 seconds in the US alone. In 2009, the estimated cost of cardiovascular disease in the United States was $475.3 billion according to the American Heart Association and the NHLBI. However, mortality rates have decreased due to improved prevention, diagnosis and treatment. This panel will discuss promising new areas of research and developing trends that are attracting funds. In Menlo Park.
Detailed Information
March 17, 2010: BayBio NEST | 7th Annual Life Sciences Investor and Entrepreneur Roundtables
The Entrepreneur and Investor Roundtables event is a unique event designed to facilitate introductions, dialogs and establish connections between life science entrepreneurs and investors. This event provides early stage companies with an accessible first step into the capital markets while providing investors a first look at intriguing innovations. The Entrepreneur and Investor Roundtables event is well known for its iconic ‘speed-dating’ format. Each year, VC firms and Angel Investors listen to brief pitches from dozens of biotech entrepreneurs. In Palo Alto.
Detailed Information
March 23: BioFacilities | Industry Knowledge for the Non-Scientist
Further your understanding of the unique real estate and facility requirements of the dynamic and highly regulated biotech and pharmaceutical industries. Be more strategic in the development and implementation of economic development strategies targeting this growth industry by understanding the language of the industry’s built environment needs. Advance your knowledge of key performance and specific uses driving the cost of developing and operating these technical facilities. Enhance your ability to provide consultative representation to property owners and tenants. Learn from well-regarded Biotech Primer instructors that have the skill and hands-on experience to teach individuals drawing from a wide variety of professions in an engaging environment. In Menlo Park.
Detailed Information
March 25, 2010: Therapeutic Breakfast Series | Establishing and Successfully Managing Strategic Alliances
The current economic climate and market pressures are forcing a change in strategy for both established and emerging life sciences companies. The IPO market is gone. The VC funding is dry. Companies, seeking to deliver new treatments and cures, are forming alliances with larger organizations at a faster pace. Some are even saying that we are witnessing a fundamental change, where success will depend on a company's capacity to manage multiple relationships as part of a larger collaborative network. To be successful, companies will need to effectively develop and manage alliances, they must also learn how to remain relevant to their partners and be flexible enough to evolve with changes in the partner's strategy. Join us for a panel of expert Alliance executives to learn how to become "alliance capable" and thrive through collaborations in the new environment. In Redwood City.
Detailed Information
March 28, 2010: Biotech Ski Trip to Alpine Meadows
Join your life sciences industry colleagues for a day of fun at Alpine Meadows! You will meet your industry peers passionate about skiing and snowboarding and we hope this leads to new relationships with your colleagues at a company next door! A bus service organized through NACSKI, a very reputable ski bus service in the bay area, will leave from the OncoMed parking lot (800 Chesapeake Dr., Redwood City) at 5:30 AM for Alpine Meadows. You can book your own spot on the bus via link below as well as buy discounted lift tickets. All are welcome, including friends and family. Contact Aaron Sato for additional information at 650-995-8221 or aaron.sato@oncomed.com. Detailed Information
Bookmark/Search this post with:
Recent comments
6 days 13 hours ago
1 week 2 days ago
21 weeks 3 days ago
21 weeks 5 days ago
24 weeks 2 days ago
26 weeks 6 days ago
29 weeks 4 days ago
33 weeks 17 hours ago
39 weeks 3 days ago
51 weeks 6 days ago